Skip to main content
. 2021 Oct 25;9(11):1241. doi: 10.3390/vaccines9111241
SARS-CoV-2 Severe acute respiratory syndrome coronavirus type 2
COVID-19 Coronavirus disease 2019
Nuc-Ab Nucleocapsid antibody
S-Ab Spike antibody
N-Ab Neutralizing antibody
ELISA Enzyme-linked immunoassay
CLIA Chemiluminescent immunoassay
HCWs Healthcare workers
T-Ab Total spike antibody
ECLIA Electro-chemiluminescent immunoassay
COI Cut-off index
CI Confidence interval